免疫功能正常患者的原发性皮肤曲霉病：口服伏立康唑治疗成功
Primary cutaneous aspergillosis in an immunocompetent patient: successful treatment with oral voriconazole.
作者信息
Craiglow Brittany, Hinds Ginette, Antaya Richard, Girardi Michael
机构信息
Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
出版信息
Pediatr Dermatol. 2009 Jul-Aug;26(4):493-5. doi: 10.1111/j.1525-1470.2009.00971.x.
Abstract
We report a case of primary cutaneous aspergillosis in an immunocompetent child that responded rapidly to oral voriconazole therapy. Voriconazole may be considered as a treatment option for pediatric patients with primary cutaneous aspergillosis.
摘要
我们报告了一例免疫功能正常儿童的原发性皮肤曲霉病，该患儿对口服伏立康唑治疗反应迅速。对于患有原发性皮肤曲霉病的儿科患者，伏立康唑可被视为一种治疗选择。
Zotero 插件